Publicacións en colaboración con investigadores/as de University of Sassari (13)

2025

  1. Therapeutic management of traumatic facial palsy: a systematic review

    European Archives of Oto-Rhino-Laryngology

2024

  1. Reliability of large language models in managing odontogenic sinusitis clinical scenarios: a preliminary multidisciplinary evaluation

    European Archives of Oto-Rhino-Laryngology, Vol. 281, Núm. 4, pp. 1835-1841

2023

  1. Comprehensive management of paranasal sinus fungus balls: A Young-IFOS consensus statement

    International Forum of Allergy and Rhinology, Vol. 13, Núm. 5, pp. 877-885

  2. Diamine Oxidase Activity Deficit and Idiopathic Rhinitis: A New Subgroup of Non-Allergic Rhinitis?

    Life, Vol. 13, Núm. 1

  3. Velopharyngeal Incompetence in Musicians: A State-of-the-Art Review

    Journal of Personalized Medicine, Vol. 13, Núm. 10

2022

  1. In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence

    Laryngoscope

  2. Long-term outcomes and cost-effectiveness of a magnet-based valve voice prosthesis for endoprosthesis leakage treatment

    European Archives of Oto-Rhino-Laryngology, Vol. 279, Núm. 8, pp. 4167-4172

  3. New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination

    Laryngoscope, Vol. 132, Núm. 2, pp. 419-421

  4. The study of laryngopharyngeal reflux needs adequate animal model

    European Archives of Oto-Rhino-Laryngology

2021

  1. Olfactory and gustatory dysfunctions are difficult to evaluate in hospitalized COVID-19 patients

    American Journal of Otolaryngology - Head and Neck Medicine and Surgery

2017

  1. Overexpression of the cytokine BAFF and autoimmunity risk

    New England Journal of Medicine, Vol. 376, Núm. 17, pp. 1615-1626

2013

  1. Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

    Antiviral Therapy, Vol. 18, Núm. 5, pp. 709-715

2010

  1. Series "update on tuberculosis" edited by C. Lange, M. Raviglione, W.W. Yew and G.B. Migliori number 2 in this series: The risk of tuberculosis related to tumour necrosis factor antagonist therapies: A TBNET consensus statement

    European Respiratory Journal, Vol. 36, Núm. 5, pp. 1185-1206